APA

Kyle R. A., Jacobus S., Friedenberg W. R., Slabber C. F., Rajkumar S. V. & Greipp P. R. (20090616). The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93. : Cancer.

Chicago

Kyle Robert A, Jacobus Susanna, Friedenberg William R, Slabber Coenraad Frederik, Rajkumar S Vincent and Greipp Philip R. 20090616. The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93. : Cancer.

Harvard

Kyle R. A., Jacobus S., Friedenberg W. R., Slabber C. F., Rajkumar S. V. and Greipp P. R. (20090616). The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93. : Cancer.

MLA

Kyle Robert A, Jacobus Susanna, Friedenberg William R, Slabber Coenraad Frederik, Rajkumar S Vincent and Greipp Philip R. The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93. : Cancer. 20090616.